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Abstract
Background
The roles of host and pathogen factors in determining innate immune responses to M. tuber-
culosis are not fully understood. In this study, we examined host macrophage immune
responses of 3 race/ethnic groups to 3 genetically and geographically diverse M. tuberculo-
sis lineages.
Methods
Monocyte-derived macrophages from healthy Filipinos, Chinese and non-Hispanic White
study participants (approximately 45 individuals/group) were challenged with M. tuberculo-
sis whole cell lysates of clinical strains Beijing HN878 (lineage 2), Manila T31 (lineage 1),
CDC1551 (lineage 4), the reference strain H37Rv (lineage 4), as well as with Toll-like recep-
tor 2 agonist lipoteichoic acid (TLR2/LTA) and TLR4 agonist lipopolysaccharide (TLR4/
LPS). Following overnight incubation, multiplex assays for nine cytokines: IL-1β, IL-2, IL-6,
IL-8, IL-10, IL-12p70, IFNγ, TNFα, and GM-CSF, were batch applied to supernatants.
Results
Filipino macrophages produced less IL-1, IL-6, and more IL-8, compared to macrophages
from Chinese and Whites. Race/ethnicity had only subtle effects or no impact on the levels
of IL-10, IL-12p70, TNFα and GM-CSF. In response to the Toll-like receptor 2 agonist lipo-
teichoic acid (TLR2/LTA), Filipino macrophages again had lower IL-1 and IL-6 responses
and a higher IL-8 response, compared to Chinese and Whites. The TLR2/LTA-stimulated
Filipino macrophages also produced lower amounts of IL-10, TNFα and GM-CSF. Race/eth-
nicity had no impact on IL-12p70 levels released in response to TLR2/LTA. The responses
to TLR4 agonist lipopolysaccharide (TLR4/LPS) were similar to the TLR2/LTA responses,
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for IL-1, IL-6, IL-8, and IL-10. However, TLR4/LPS triggered the release of less IL-12p70
from Filipino macrophages, and less TNFα from White macrophages.
Conclusions
Both host race/ethnicity and pathogen strain influence the innate immune response. Such
variation may have implications for the development of new tools across TB therapeutics,
immunodiagnostics and vaccines.
Introduction
Genotyping of Mycobacterium tuberculosis (M. tuberculosis) has shown that lineages of the
organism have predilections for certain geographic distributions and dominate certain geo-
graphic areas [1–4]. Members of the East Asian lineage (that includes the Beijing family) are
predominant in East Asia, members of the Indo-Oceanic lineage are predominant in the Phil-
ippines and around the rim of the Indian Ocean [5], and members of the M. africanum West
Africa I and II are largely restricted to West Africa [1, 6]. This global distribution of strains
may not be random or based solely upon variabilities in virulence, but may be partly deter-
mined by the genetics, epigenetics and other factors of the host and the microbe, both of
which are under natural selection forces.
Successful containment of infection with M. tuberculosis is dependent on innate immune
responses, as these responses play a central role in the acquisition of the adaptive T cell
response, in granuloma formation, and ultimately in the containment of intracellular growth
of M. tuberculosis [7]. The cells responsible for the containment of intracellular infection, den-
dritic cells and alveolar macrophages, are also the preferred intracellular host of M. tuberculo-
sis. Central to the function of these cells is responsiveness to bacterially derived patterns, that
are recognized by Toll-like receptors (TLR). There is evidence that TLRs play an important
role in the host immune response to M. tuberculosis [7]. Alveolar macrophages are the first
responders to inhalation of tubercle bacilli and represent an important component of the
innate response to M. tuberculosis infection. Exposure of macrophages to M. tuberculosis
results in the secretion of cytokines, including TNFα, GM-CSF, IL-1α, IL-1β, IL-6, IL-8, IL-10,
and IL-12p70, that play key roles in granuloma formation [8–10]. Two members of the mam-
malian TLR family, TLR2 and possibly TLR4, have been found to recognize mycobacterial
products and to mediate macrophage activation and the ensuing production of particular cyto-
kines [7, 11]. The discovery of TLR polymorphisms that are associated with race/ethnicity and
response to particular pathogens, raises the distinct possibility that there are ethnicity-specific
differences in TLR2 and/or TLR4, resulting in differential innate responses to M. tuberculosis
strains [12–16]. Such immunologic differences in innate response are of interest given the
molecular epidemiologic studies demonstrating differences in the transmissibility and viru-
lence of M. tuberculosis based on strain [17] [18–20]. Differential activation through TLRs
could have a significant impact on the host response to infection with M. tuberculosis, and ulti-
mately to disease progression.
Our study explores the interaction of host and pathogen factors on the innate immune
response. Based on the molecular epidemiology of TB in San Francisco, which includes a siz-
able population of Asian patients [17, 21], we selected 3 race/ethnic groups, Filipinos, Chinese,
and non-Hispanic Whites for inclusion in our study. From these healthy donors, macrophages
were isolated and treated with lysates from 4 M. tuberculosis strains, comprising 3
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predominant lineages identified in San Francisco (East Asian [Beijing HN878], Indo-Oceanic
[Manila T31] and EuroAmerican [CDC1551]), and one laboratory reference strain (H37Rv),
or with agonists of TLR2 (lipoteichoic acid LTA) or TLR4 (lipopolysaccharide LPS). A total of
9 cytokines were measured. This study adds to the growing body of evidence that differential
innate immune responses contribute to ethnicity-associated differences in TB susceptibility.
Methods
Ethics statement
The “Innate Immunity to TB” (IITB) study protocol was reviewed and approved by the com-
mittee on human research at the University of California, San Francisco (CHR# H45279-
29459). Written informed consent was obtained from all study participants.
Study design and participants
Healthy volunteers, aged 18 to 55, self-identifying as Chinese, Filipino, or non-Hispanic White
were invited to participate in the study. Recruitment was through bulletin board postings at
the Schools of Dentistry, Medicine, Nursing, Pharmacy, Physical Therapy of the University of
California, San Francisco, and at the undergraduate and graduate schools of San Francisco
State University. Between 2009 and 2011, all consenting volunteers meeting inclusion and hav-
ing no exclusion criteria were consecutively enrolled into IITB. Recruitment continued until
50 participants per race/ethnic group were enrolled. All volunteers completed a standardized
questionnaire reviewing demographics, health history as well as information on potential risk
factors for TB. All volunteers reported the race/ethnicity of their biological parents and grand-
parents, and only those identifying both generations as Chinese, Filipino or non-Hispanic
White were eligible for participation in the study. Those reporting a history of active TB, evi-
dence of prior TB on chest radiograph, vaccination with Mycobacterium bovis bacillus Calm-
ette-Gue´rin (BCG) vaccine in the past 15 years, co-morbid conditions including diabetes,
renal disease, cancer, hepatitis, HIV/AIDS, or other moderate or high risk characteristics asso-
ciated with TB, such as homelessness or history of incarceration, significant alcohol use
(greater than 2 drinks per day), tuberculin skin testing within past 6 months, or treatment with
any immunomodulating agents such as corticosteroids, were not eligible to participate. All
participants had IFN-γ release assay testing, specifically Quantiferon-Gold1 (QFT), for latent
TB infection at the time of study enrollment.
Mycobacterial strains, TLR agonists
Whole cell lysates of Beijing HN878, Manila T31, CDC1551, and H37Rv, were obtained from
gamma-irradiated cells as described previously [22]. The total protein content from each
whole cell lysate batch was quantified by bicinchoninic acid assay (ThermoFisher Scientific,
Walthham, MA), and samples were portioned into individual 10 mg vials and stored at -80c
until use. Certificates of Analysis and Product Information Sheets for whole cell lysates are
available through the National Institute of Allergy and Infectious Diseases funded BEI
Resources (http://www.beiresources.org/; catalog numbers: NR-14820, NR-14821, NR-14824,
NR-36496).
Isolation, culture and ex vivo stimulation of Monocyte Derived
Macrophages (MDMs)
For each study participant, phlebotomy was performed to fill four BD Vacutainer1 CPT™ Cell
Preparation Tube with Sodium Citrate (Becton, Dickinson and Company, Franklin Lakes, NJ,
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No. 362761). Whole blood was processed according to manufacturer guidance for the separa-
tion of mononuclear cells. Monocytes were prepared from freshly drawn blood samples
through negative selection using the Miltenyi Biotec Monocyte Isolation Kit II, which provides
an indirect magnetic labeling approach for the isolation of untouched monocytes from human
peripheral blood mononuclear cells (PBMCs). Monocytes were counted and resuspended at
5x105/ml in 10% vol/vol human serum (HuS), and then plated at 500,000/well in ultralow
adherence plates, without stimulation, and incubated at 37˚C with CO2 for 72 hours to obtain
enrichment of monocyte-derived macrophages (MDMs) through adherence. Upon harvesting
of MDMs, viability was assessed by absence of uptake of trypan blue, and purity (ranging 96–
98% MDMs) was determined by fluorescence cell sorter (FACS). We further assessed viability
on the basis of HLA-DR and CD11c, and T cell contamination on the basis of CD3. MDMs
from each study participant, were incubated at 1x105 for 18 hours with 10 ug / ml whole cell
lysate of M. tuberculosis strains, and to agonists of TLR2 (10 ug / ml Lipoteichoic acid (LTA)
from S. aureus, Sigma, L 2515) and TLR4 (50 ng/ml lipopolysaccharide (LPS) from E. coli
Sigma, L-2880); and culture medium (negative control). Following overnight incubation,
supernatants were collected and frozen at -80˚C and batch tested using MSD Human ProIn-
flammatory 9-Plex Tissue Culture Kit K15007B-1 (measuring GM-CSF, IFN-γ, IL-1β, IL-10,
IL-12p70, IL-2, IL-6, IL-8, TNF-α) run on a Meso Scale Diagnostics MESO QuickPlex SQ 120
instrument.
Statistics and analysis
Categorical demographic factors were analyzed using chi squared tests; age was compared by
race using the Student’s t-test. Geometric mean cytokine responses were compared in response
to 6 stimulants (4 M. tuberculosis strains: H37Rv “reference strain,” CDC1551 “EuroAmeri-
can,” HN878 “East Asian,” and T31 “Indo-Oceanic;” and 2 stimulants on TLR pathways: LTA
and LPS) and by race (White, Chinese, and Filipino). For analyses where stimulant was held
constant and responses were compared by race, linear regression was used, adjusting for inde-
pendent factors age and gender. For analyses where race was held constant and participant
responses to each stimulant were compared, a general estimating equation (GEE) was added
to the linear regression to adjust for responses clustered by participant, in addition to adjusting
for age and gender [23]. Multivariable linear regression models were used to assess interplay
between race and strain as predictors of cytokine response. P values were adjusted for multiple
testing error using the false discovery rate (FDR) method, and significance was defined at the
p< 0.20 level [24].
Cytokines were measured in picograms (pg), logged to approximate a normal distribution
for analysis, and presented as geometric means with 95% confidence intervals. The upper limit
of detection (ULOD) was 10,000 pg for all cytokines; values above the ULOD were set to
10,000 pg. The lower limits of detection (LLOD) were unique for each cytokine; values below
the LLOD were left unchanged. All statistical analyses were performed using SAS version 9.4
(SAS Institute, Cary, NC, USA).
Results
Study population
The study population included 137 healthy donors with mean age 30±8 (range 19–55) years of
age. Most were female (n = 99, 72%), and 39% were foreign-born (n = 54). A positive QFT test
was uncommon (8%) and more likely to occur among the foreign-born (RR 15.4, 95%CI
2–116). Self-identified race was divided approximately evenly: non-Hispanic White (n = 46),
Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0195392 May 22, 2018 4 / 16
Chinese (n = 47), or Filipino (n = 44). Filipinos were on average older, and Whites were less
likely to be foreign-born (Table 1).
Cytokine levels
We prepared monocyte-derived macrophages (MDMs) from healthy study participants
(n = 137), and incubated the cells with M. tuberculosis lysates. The concentration of cytokines
released in response to the bacterial lysates were measured using 2 different platforms (Lumi-
nex Assay and Meso Scale Discovery immunoassay (MSD); Meso Scale Discovery, Gaithers-
burg, Maryland) according to manufacturer instructions. Since the cytokine levels and trends
were identical for these 2 platforms, we describe our data generated with the MSD kit. We
measured a total of 9 cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12p70, IFNγ, TNFα, and
GM-CSF. As the study was designed to assess macrophage stimulation, the T cell cytokines
IFN-γ and IL-2 were included as controls. IFNγ and IL-2, at the lower limit of detection was
noted, possibly due T cell contamination.
Cytokine response to M. tuberculosis strain by race/ethnicity
We observed similar patterns across all 4 M. tuberculosis strains for IL-1b, IL-6 and IL-8 (Fig 1
and S1 Table). Filipino MDMs produced less IL-1 and IL-6, but more IL-8, compared to
MDMs from Whites and Chinese. We observed subtle differences across M. tuberculosis
strains for TNFα, and GM-CSF. For TNFα, Filipino and White MDMs released less compared
to Chinese MDMs, in response to CDC1551. Filipino MDMs released less of this cytokine
than Chinese cells, in response to H37Rv, and Filipino MDMs released less TNFα than both
Chinese and White MDMs in response to T31. There was no difference by race/ethnicity in
the amounts of TNFα released in response to HN878. Only strain T31 triggered the release of
different GM-CSF amounts across race/ethnic groups: Filipino MDMs released less of this
cytokine, compared to Chinese MDMs (Fig 1 and S1 Table). There were no race/ethnic differ-
ences in IL-10 and IL-12p70 responses to any of the M. tuberculosis strains (S1 Table).
Cytokine response to TLR agonists by race/ethnicity
MDMs were incubated for 18 hours with the TLR2 agonist LTA or the TLR4 agonist LPS, and
cytokine responses were measured.
In response to TLR2/LTA, Filipino MDMs released lower amounts of IL-1, IL-6, IL-10,
TNFα and GM-CSF, but higher amounts of IL-8, compared to Whites and Chinese (Fig 2 and
S2 Table). There were no differences by race/ethnicity in the IL-12p70 response to TLR2/LTA
(S2 Table).
Table 1. Demographic characteristics of the study population.
p value
White Chinese Filipino White
vs. Chinese
White
vs. Filipino
Chinese
vs.
Filipino
n (%) 46 (34) 47 (34) 44 (32)
Mean age±SD
(Range)
28.3±6.8 (22–53) 28.7±8.3 (19–55) 32.9±7.1 (22–49) 0.815 0.002 0.005
Female, n (%) 30 (65) 34 (73) 35 (80) 0.459 0.132 0.423
Foreign birth, n (%) 5 (11) 22 (47) 27 (61) <0.001 <0.001 0.165
QFT positive, n (%) 1 (2) 4 (9) 6 (14) 0.201 0.071 0.436
https://doi.org/10.1371/journal.pone.0195392.t001
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In response to TLR4/LPS, Filipino MDMs released lower amounts of IL-1, IL-6, IL-10, IL-
12p70 but higher amounts of IL-8, compared to Whites and Chinese, while White MDMs
released lower amounts of TNFα, compared to Chinese (Fig 2 and S2 Table). There were no
differences across race/ethnicity groups in the GM-CSF responses to TLR4/LPS (S2 Table).
Cytokine response by M. tuberculosis strain
We explored the impact of M. tuberculosis strain on cytokine responses within each race/eth-
nicity (S1 Fig and S3 Table). Strain CDC1551 elicited lower levels of IL-1, IL-6, IL-10, TNFα
and GM-CSF, and higher levels of IL-8, compared to all other strains, regardless of race/eth-
nicity. Strain T31 triggered the release of more IL-12p70 compared to the other strains, regard-
less of race/ethnicity. These data indicate that the clinical M. tuberculosis strains CDC1551 and
T31 may have different immunogenic profiles, compared to M. tuberculosis strains H37Rv and
HN878, recognizing that cellular lysates are a crude proxy of infection.
Cytokine response by both race/ethnicity and strain
Using a multivariable linear regression model predicting response of macrophages to M. tuber-
culosis lysates and race/ethnicity, adjusted for age and gender, Filipino ethnicity was an inde-
pendent predictor of lower IL-1 and IL-6 response, and of higher IL-8 response compared to
Whites (Table 2). CDC1551 strain was an independent predictor of lower IL-1, IL-6, IL-10,
TNFα, and GM-CSF response, and of higher IL-8 response compared to the reference strain
H37RV. In addition, T31 (Manila strain) was an independent predictor of lower IL-8 activity,
and higher activity in IL-1, IL-6, IL-10, IL-12p70, TNFα, and GM-CSF compared to H37RV.
HN878 strain was independently predictive of lower IL-8, TNFα, and GM-CSF response com-
pared to H37RV. When multiple testing correction is applied no significant interactions
emerged.
Discussion
In this study of the response of macrophages derived from healthy individuals of 3 race/ethnic
groups to M. tuberculosis lysates from 4 phylogeographic strains of the organism, we found
that both host race/ethnicity and pathogen strain influence the innate immune response.
We found that macrophages from Filipinos produced less IL-1, IL-6, and more IL-8, com-
pared to macrophages from Chinese and Whites participants. In response to the Toll-like
receptor 2 agonist LTA, Filipino macrophages again had lower IL-1 and IL-6 responses and a
higher IL-8 response, compared with Chinese and Whites. The TLR2/LTA-stimulated Filipino
macrophages also produced lower amounts of IL-10, TNFα and GM-CSF, and the TLR4/LPS
triggered the release of less IL-12p70 from Filipino macrophages, and less TNFα from White
macrophages. These data would suggest that the induction of, IL-6, TNF-α, GM-CSF could be
associated with TLR2 ligation. Unexpectedly, the induction of IL-8 appeared to be distinct
from that of IL-6. In this regard, induction of both IL-6 and IL-8 via TLR-2 are both MyD88
dependent [25]. The differential response of IL-8 would imply either that other receptors
might play a selective role in IL-8 induction. For example, the mannose receptor has been pre-
viously demonstrated to enable TLR-2 dependent IL-8 production. Similarly, Dectin1 and
Fig 1. Cytokine response of macrophages to M. tuberculosis strains by race/ethnicity. Cytokines released by macrophages derived from healthy
individuals of three ethnicities in response to M. tuberculosis lysates from four strains. Comparisons are adjusted for age and gender. Brackets indicate
FDR-adjusted p< 0.20.
https://doi.org/10.1371/journal.pone.0195392.g001
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CD36 could modulate TLR responsiveness. Interestingly, M. tuberculosis can activate leuko-
cytes via the mannose receptor [26], although this possibility has not been formally tested.
We also examined the effect of pathogen strain using lysates prepared from 4 M. tuberculo-
sis strains: clinical strains Beijing HN878 (lineage 2), Manila T31 (lineage 1) and CDC1551
(lineage 4), and reference strain H37Rv (lineage 4. We found that CDC1551 elicited a
markedly different macrophage response, for most of the cytokines, eliciting less IL-1, IL-6,
IL-10, TNFα, and GM-CSF, and more IL-8, compared with other M. tuberculosis strains.
These data would appear to parallel those seen for specific TLR-2 stimulation. Our data, then,
would suggest that both differential responses to each strain, as well as those seen among the
race/ethnic groups are driven by TLR-2 signalling, and would not support the original hypoth-
esis that each strain would be “tuned” to its concordant, geographically-aligned host.
TB susceptibility and disease outcome vary greatly among individuals, and it is well estab-
lished that at least some of this variability is attributable to host genetics [27–31]. Genetic loci
that may influence clinical TB phenotypes have been identified [31–35]. Most of these genes
encode immune response proteins [31, 36–38]. Here, responsiveness and/or production of
IFN-γ has been frequently observed as strongly associated with vulnerability to mycobacterial
infection. With regard to TLRs it has been argued that TLR signaling specifically has “yet to
provide convincing evidence of a major contribution of common variants of human TLRs, IL-
1Rs, or their adaptors to host defense” [39]. Nonetheless, there a number of examples where
specific TLRs or molecules related to TLR signaling can be associated with vulnerability to
Fig 2. Cytokine response of macrophages to Toll-like receptor agonists by race/ethnicity. Cytokines released by
macrophages derived from healthy individuals of three ethnicities in response to TLR2 agonist lipoteichoic acid (LTA)
and TLR4 agonist lipopolysaccharide (LPS). Comparisons are adjusted for age and gender. Brackets indicate FDR-
adjusted p< 0.20.
https://doi.org/10.1371/journal.pone.0195392.g002
Table 2. Seven multivariable linear regression models predicting response of macrophages to M. tuberculosis lysates and race/ethnicity, adjusted for age and gender.
General estimating equation included to adjust for values clustered by participant. P values adjusted for multiple testing using the false discovery rate (FDR) method.
IL-1 IL-6 IL-8 IL-10 IL-12p70 TNFα GM-CSF
Estimate
(95%CI)
p value Estimate
(95%CI)
p value Estimate
(95%CI)
p value Estimate
(95%CI)
p value Estimate
(95%CI)
p
value
Estimate
(95%CI)
p value Estimate
(95%CI)
p value
Race
White Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00
Chinese 0.06 (-0.41,
0.53)
.890 -0.05 (-0.67,
0.57)
.929 -0.02 (-0.21,
0.18)
.929 0.02 (-0.43,
0.47)
.949 -0.08 (-0.48,
0.32)
.868 0.19 (-0.05,
0.43)
.224 0.27 (-0.15,
0.70)
.332
Filipino -0.76 (-1.2,
-0.36)
.001 -0.70 (-1.2,
-0.17)
.023 0.22 (0.04,
0.39)
.032 -0.15 (-0.57,
0.27)
.686 -0.20 (-0.66,
0.25)
.577 -0.11 (-0.37,
0.14)
.577 -0.12 (-0.52,
0.27)
.756
Strain
H37RV Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00
CDC1551 -0.92 (-1.0,
-0.79)
< .001 -1.2 (-1.3,
-1.1)
< .001 0.51 (0.45,
0.57)
< .001 -1.0 (-1.1,
-0.93)
< .001 -0.03 (-0.20,
0.14)
.868 -0.53 (-0.64,
-0.43)
< .001 -1.0 (-1.1,
-0.88)
< .001
HN878 -0.02 (-0.14,
0.10)
.868 -0.03 (-0.15,
0.08)
.787 -0.20 (-0.30,
-0.10)
< .001 0.06 (-0.08,
0.19)
.577 0.18 (-0.05,
0.41)
.224 -0.16 (-0.29,
—0.03)
.035 -0.15 (-.26,
-0.04)
.013
T31 0.20 (0.11,
0.30)
< .001 0.30 (0.21,
0.39)
< .001 -0.20 (-0.24,
-0.15)
< .001 0.15 (0.10,
0.21)
< .001 0.17 (0.10,
0.24)
<
.001
0.13 (0.07,
0.19)
< .001 0.20 (0.14,
0.27)
< .001
Covariates
Age -0.04 (-0.06,
-0.02)
.001 -0.04 (-0.07,
-0.01)
.025 0.02 (0.01,
0.03)
.002 0.00 (-0.02,
0.02)
.988 -0.04 (-0.06,
-0.01)
.010 -0.01 (-0.03,
0.00)
.290 -0.03 (-0.05,
-0.01)
.032
Male 0.07 (-0.36,
0.50)
.868 0.04 (-0.50,
0.58)
.929 -0.03 (-0.21,
0.15)
.868 -0.39 (-0.80,
0.02)
.121 0.32 (-0.04,
0.67)
.151 0.04 (-0.19,
0.27)
.868 0.06 (-0.33,
0.45)
.868
https://doi.org/10.1371/journal.pone.0195392.t002
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infection with Mtb [15, 16], or to altered responsiveness to immunization with BCG [40]. Our
data with regard to TLR2 responsiveness strongly supports genetic variation in TLR2
signaling.
The impact of ethnicity on TB susceptibility was revealed over a quarter century ago [41].
One of the first studies to dissect the relative influence of ethnicity and M. tuberculosis strain
on TB disease phenotype showed that ethnicity is a powerful predictor of disease phenotype,
independently of pathogen strain [42]. However, few studies have addressed the basis of these
ethnic differences at the cellular and molecular levels. At the cellular level, one report has sug-
gested that the ability of M. tuberculosis to grow in macrophages varies according to the ethnic-
ity of the macrophage donor [43]. At the molecular level, a TLR2 polymorphism appears to be
associated with TB susceptibility in Asians, but not in Caucasians [44], and inflammatory
mediator levels are associated with ethnicity in pulmonary TB patients of African and Eurasian
ancestry [45]. These ethnic differences are associated with ethnic variation in host vitamin D
binding protein DBP phenotype, in accord with the demonstrated roles of the DBP protein in
macrophage activation and neutrophil chemotaxis [46, 47]. Here, we show that macrophages
derived from healthy Filipino donors had markedly different innate immune responses to M.
tuberculosis lysate, to TLR2 stimulation with LTA, and to TLR4 stimulation with LPS, as com-
pared with macrophages from non-Hispanic Whites and Chinese. It will be of interest to
expand these studies to other ethnicities, including Africans, African-Americans and
Hispanics.
At present, information regarding ethnic differences in TLR SNPs is limited. For example,
one ethnic-specific difference is SNP TLR1 rs5743618 (changes T to G at bp 1805 and changes
I to S at aa 602) [48]. This SNP regulates IL6 response to PAM3 stimulation, presumably via
the ligation of the TLR1/2 heterodimer. The high responding variant is dominant in Asians
(99% T) and Blacks (75%) while the low responding variant dominates in Whites and (75%).
The entire TLR1/2/6 locus is an evolutionary hot spot under positive selection [48].
Many epidemiological and experimental studies have shown that M. tuberculosis strains
produce different disease phenotypes and immune responses [20, 49–51]. This clinical pheno-
type diversity across M. tuberculosis strains is likely attributable to differing gene expression
[51–53], metabolic profiles [54], cell wall lipids [55] and growth rates in macrophages [56]. We
show here that clinical strain CDC1551 (lineage 4 modern) triggers the release of less IL-1, IL-
6, IL-10, TNFα, and GM-CSF, and more IL-8, compared with clinical strains Beijing HN878
(lineage 2 modern), Manila T31 (lineage 1 ancient) and reference strain H37Rv (lineage 4
modern). Our results are in accord with those of Subbian et al, who reported that rabbits
infected with CDC1551 produced less lung TNFα mRNA compared to rabbits infected with
HN878, although, contrary to our data, they found that CDC1551 also triggered the produc-
tion of less IL-8 mRNA [57]. As IL-8 is associated with neutrophilc inflammation, it was postu-
lated that this was one reason that CDC1115 induced less cavitation. Manca et al. compared
the innate immune responses elicited by strains CDC1551, HN878 and H37Rv, with results
that are not congruent with our study. Mice infected with CDC1551 produced more IL-6 and
IL-10 mRNA than HN878 and H37Rv, and more TNFα mRNA than HN878 [58, 59], and
human monocytes infected with CDC1551 produced more IL-10 and TNFα mRNA than cells
infected with HN878 [60]. These discordant results likely reflect different experimental sys-
tems, and it is notable that the earlier studies relied on small sample sizes.
The molecular bases for these innate immune response differences across host ethnicity
and M. tuberculosis pathogen lineages are largely unknown. However, comparative genomics,
and ongoing efforts to understand the unusual biology of these bacteria, including unbiased
systems biology approaches [51, 61], are expected to yield insights. Furthermore, our work
would support a detailed evaluation of TLR-2 dependent signaling across each of these species.
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Our study has limitations, principally that our experimental system did not include a model
in which macrophages were infected with live M. tuberculosis. We recognize that the use of cel-
lular lysates represents a proxy of infection useful for comparisons rather than definitive deter-
mination of immunogenicity of strains. Also, whereas macrophages for all assays were
enumerated at 50,000 cells/well, we did not enumerate circulating monocytes in volunteers
nor evaluate for cell surface expression, which may have affected induced cytokine differences.
Additionally, due to the multiplexed nature of assays and resource limitations, we were unable
to conduct diluted assays, resulting in a censored upper limit of detection. Finally, ethnicity
was determined based on self-report rather than genetic testing. Whereas, it has been shown
that self-definitions of ethnicity are highly accurate reflection of true ethnic identity in Chinese
and Whites, in particular, there is the potential for misclassification of ethnicity [62]. Our
study also has a number of strengths. First, the immunologic responses to M. tuberculosis were
evaluated using cells from healthy individuals and focused on innate immunity, thus reducing
the influence of adaptive immunity, history of TB exposure, as well as environmental and
socioeconomic factors. Second, our controlled experimental design allowed us to examine the
interaction of host and pathogen genetics. Third, our study population of 137 healthy macro-
phage donors lends considerable robustness to our results.
In sum, our data show that that both host race/ethnicity and pathogen factors influence the
innate immune response and such variation has implications for the development of new tools
across TB therapeutics, immunodiagnostics and vaccines [3, 45, 63].
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